MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human

V Raj1, H C Liang, N D Woodward

  • 1Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN 37072, USA.

Insights

3,4-methylenedioxymethamphetamine (MDMA) use is linked to reduced brain activation in areas crucial for verbal memory. This neurobiological finding may explain persistent memory deficits in MDMA users.

Area of Science:

  • Neuroscience
  • Cognitive Psychology
  • Neuroimaging

Background:

  • 3,4-methylenedioxymethamphetamine (MDMA) use is associated with verbal memory impairments.
  • Previous studies show reduced grey matter in specific brain regions (Brodmann areas 18, 21, 45) in MDMA users.
  • These regions are implicated in verbal memory functions.

Purpose of the Study:

  • To investigate if MDMA users exhibit altered brain activation in key verbal memory regions during a semantic verbal memory task using fMRI.
  • To correlate lifetime MDMA use with brain activation patterns and task performance.

Main Methods:

  • Functional magnetic resonance imaging (fMRI) was used to measure brain activation during a semantic memory encoding and recognition task.
  • Participants were polysubstance users with significant MDMA exposure.
  • Blood oxygen level-dependent (BOLD) signal change in left Brodmann areas (BA) 9, 18, 21/22, and 45 were primary outcomes.

Main Results:

  • MDMA use was associated with decreased brain activation in left BA 9, 18, and 21/22 during semantic recognition.
  • This effect was partly influenced by concurrent use of cannabis and cocaine.
  • No significant association was found between MDMA exposure and accuracy or response time in the semantic recognition task.

Conclusions:

  • MDMA exposure is linked to reduced regional brain activation in areas critical for verbal memory during semantic recognition.
  • These neuroimaging findings provide a potential neural mechanism for the observed verbal memory deficits in MDMA users.
  • The results partially corroborate previous structural findings of reduced grey matter in MDMA users.